All In Biotech

Drug Trial Radar · NCT01518374

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Last checked: Nov 19, 2026Latest source record: Jul 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,768

Actual

Start

Dec 2009

Primary completion

May 3, 2017

Study completion May 3, 2017

Sponsor

Lead sponsor
Avid RadiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jan 26, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion protocol) such as longitudinal studies of aging and studies of biomarkers for neurodegenerative diseases.

Conditions

  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Neurodegenerative Diseases

Interventions

  • Florbetapir F 18Drug

    370 MBq (10 mCi)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Experiencing Treatment-emergent Adverse Events Considered Related to Florbetapir AdministrationTime frame: 48 hours

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Health

    Phoenix, Arizona

  • Banner Sun Health Research Institute

    Sun City, Arizona

  • UC Davis

    Davis, California

  • UC Irvine

    Irvine, California

  • University of Southern California

    Los Angeles, California

  • UC Irvine

    Orange, California

  • UC San Francisco

    San Francisco, California

  • UC San Francisco Memory Center

    San Francisco, California

  • Mayo Clinic Jacksonville

    Jacksonville, Florida

  • Mt. Sinai Medical Center

    Miami Beach, Florida

  • Northwestern University

    Chicago, Illinois

  • University of Kansas

    Kansas City, Kansas

  • Johns Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Washington University School of Medicine

    St Louis, Missouri

  • Duke University

    Durham, North Carolina

  • Wake Forest University

    Winston-Salem, North Carolina

  • Jefferson

    Philadelphia, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Butler Hospital

    Providence, Rhode Island

  • University of Tennessee

    Knoxville, Tennessee

  • Vanderbilt

    Nashville, Tennessee

  • UTSW

    Dallas, Texas

  • UTSW

    Dallas, Texas

  • UTSW

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.